The use of Cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 1, 2000, Pages 14-20

  Kerr, Kim M ^a,b,c   Auger, William R ^a,b   Marsh, James J ^a,b   Comito, Roberta M ^a,b   Fedullo, Rebekah L ^a,b   Smits, Gerard J ^a,b   Kapelanski, David P ^a,b   Fedullo, Peter F ^a,b   Channick, Richard N ^a,b   Jamieson, Stuart W ^a,b   Moser, Kenneth M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CYTEL CORPORATION   (United States)

^c Division of Pulmonary and Critical Care Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CY 1503; CYLEXIN; PADGEM PROTEIN; PLACEBO; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDARTERECTOMY; ENDOTHELIUM; FEMALE; HUMAN; LUNG LAVAGE; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY;

EID: 0033928049     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.1.9712142     Document Type: Article

References (17)

1. 1. Auger, W. R., K. M. Moser, R. M. Comito, K. M. Kerr, J. L. Bernardi, and R. G. Spragg. 1994. Efficacy of intravenous ICI 200,880 in the prevention of adult respiratory distress syndrome in patients undergoing pulmonary thromboendartarectomy (abstract). Am. J. Respir. Crit. Care Med. 149:A1032.
2. 2. Kerr, K. M., W. R. Auger, J. J. Marsh, R. M. Comito, D. P. Kapelanski, and K. M. Moser. 1997. Selectin blockade with CY-1503 may prevent reperfusion lung injury following pulmonary thromboendarterectomy (abstract). Am. J. Respir. Crit. Care Med. 155:A898.
3. 3. Mulligan, M. S., M. J. Polley, R. J. Bayer, M. F. Nunn, J. C. Paulson, and P. A. Ward. 1992. Neutrophil-dependent acute lung injury. J. Clin. Invest. 90:1600-1607.
4. 4. Talbott, G. A., S. R. Sharar, J. M. Harlan, and R. K. Winn. 1994. Leukocyte-endothelial interactions and organ injury: the role of adhesion molecules. New Horizons 2:545-553.
5. 5. Mulligan, M. S., J. B. Lowe, R. D. Larsen, J. Paulson, Z. Zheng, S. DeFrees, K. Maemura, M. Fukuda, and P. A. Ward. 1993. Protective effects of sialylated oligosaccharides in immune complex-induced acute lung injury. J. Exp. Med. 178:623-631.
6. 6. Mulligan, M. S., J. C. Paulson, S. DeFrees, Z. Sheng, J. B. Lowe, and P. A. Ward. 1993. Protective effects of oligosaccharides in P-selectin-dependent lung injury. Nature 364:149-151.
7. 7. Murray, J. F., M. A. Matthay, J. Luce, and M. R. Flick. 1988. An expanded definition of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 138:720-723.
8. 8. Redinbaugh, M. G., and R. B. Turley. 1986. Adaption of the bicinchoninic acid protein assay for use with microtiter plates and sucrose gradient fractions. Anal. Biochem. 153:267-271.
9. 9. Seekamp, A., G. O. Till, M. S. Mulligan, J. C. Paulson, D. C. Anderson, M. Miyasaka, and P. A. Ward. 1994. Role of selectin in local and remote tissue injury following ischemia and reperfusion. Am. J. Pathol. 144:592-598.
10. 10. Hansbrough, J. F., T. Wikström, M. Braide, M. Tenenhaus, O. H. Rennekampff, V. Kiessig, R. Zapata-Sirvent, L. M. Bjursten. 1996. Effects of E-selectin and P-selectin blockade an neutrophil sequestration in tissues and neutrophil oxidative burst in burned rats. Crit. Care Med. 24:1366-1372.
11. 11. Silver, M. J., J. M. Sutton, S. Hook, P. Lee, J. L. Malycky, L. Phillips, S. G. Ellis, E. J. Topol, and F. A. Nicolini. 1995. Adjunctive selectin blockade successfully reduces infarct size beyond thrombolysis in the electrolytic canine coronary artery mode. Circulation 92:492-499.
12. 12. Tedder, T. F., D. A. Steeber, A. Chen, and P. Engel. 1995. The selectins: vascular adhesion molecules. FASEB J. 9:866-873.
13. 13. Lasky, L. A. 1992. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 258:964-969.
14. 14. Dunlop, L. C., M. P. Skinner, L. J. Bendall, E. J. Favaloro, P. A. Castaldi, J. J. Gorman, J. R. Gamble, M. A. Vadas, and M. C. Berndt. 1992. Characterization of GMP-140 (p-selectin) as a circulating protein. J. Exp. Med. 175:1147-1150.
15. 15. Gamble, J. R., M. P. Skinner, M. C. Berndt, and M. A. Vadas. 1992. Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP 140. Science 249:414-417.
16. 16. Wong, C. S., J. R. Gamble, M. P. Skinner, C. M. Lucas, M. C. Berndt, and M. A. Vadas. 1991. Adhesion protein GMP 140 inhibits superoxide anion release by human neutrophils. Proc. Natl. Acad. Sci. U.S.A. 88:2397-2401.
17. 17. Sakamaki, F., A. Ishizaka, M. Handa, S. Fujishima, T. Urano, K. Sayama, H. Nakamura, M. Kanazawa, T. Kawashiro, M. Katayam, and Y. Ikeda. 1995. Soluble form of P-selectin in plasma is elevated in acute lung injury. Am. J. Respir. Crit. Care Med. 151:1821-1826.